Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ROIVANT SCIENCES LTD
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 2.1M shares of ROIV (ROIVANT SCIENCES LTD), worth $45.2M as of 2025-Q4. The position was decreased (-1.8% shares). ROIV represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$45.2M
Current Shares
2.1M
Total Value Change
+$28.9M
Total Shares Change
+540,384
Other major holders of ROIV: FMR LLC, MORGAN STANLEY, SB INVESTMENT ADVISERS (UK) LTD, VANGUARD GROUP INC
Decreased |
| 2.1M |
-1.8% |
| $45.2M |
| 0.0% |
| $21.63 |
0 |
| 2025-Q3 | Decreased | 2.1M | -23.5% | $32.1M | 0.0% | $15.10 | 0 |
| 2025-Q2 | Increased | 2.8M | +13.5% | $31.3M | 0.0% | $11.39 | 33 |
| 2025-Q1 | Increased | 2.4M | +1.4% | $24.7M | 0.0% | $10.38 | 29 |
| 2024-Q4 | Increased | 2.4M | +4.5% | $28.5M | 0.0% | $11.43 | 30 |
| 2024-Q3 | Increased | 2.3M | +49.4% | $26.6M | 0.0% | $11.48 | 40 |
| 2024-Q2 | Increased | 1.5M | +34.9% | $16.3M | 0.0% | $10.57 | 36 |